Merion Station, PA, United States of America

Mark L Tykocinski

USPTO Granted Patents = 15 (Patent Applications = 12)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 1.4

ph-index = 7

Forward Citations = 208(Granted Patents)

Location History:

Philadelphia, PA (US) (2008)
Merion Station, PA (US) (2001 - 2023)

Company Filing History:

7 out of 528

Thomas Jefferson University

patents

5 out of 2,596

University of Pennsylvania

patents

2 out of 2

Tr Associates, L.l.c.

5. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378322 - Fusion proteins that facilitate cancer cell destruction (2025-08-05),

2. 11702458 - PD1-41BBL fusion protein and methods of use thereof (2023-07-18),

3. 11332539 - Fusion proteins that facilitate cancer cell destruction (2022-05-17),

4. 10533054 - Agonist fusion protein for CD40 and OX40 and methods of stimulating the immune system (2020-01-14),

5. 10364279 - PD-L1 and PD-L2-based fusion proteins and uses thereof (2019-07-30),

6. 9873747 - Fusion proteins that facilitate cancer cell destruction (2018-01-23),

7. 9834610 - Fusion proteins for modulating regulatory and effector T cells (2017-12-05),

8. 9657082 - PD-L1 and PD-L2-based fusion proteins and uses thereof (2017-05-23),

9. 9221895 - OX40/TRAIL fusion proteins (2015-12-29),

10. 8329657 - Fn14/TRAIL fusion proteins and method of treating cancer (2012-12-11),

11. 8039437 - Fn14/TRAIL fusion proteins (2011-10-18),

12. 7569663 - Chimeric proteins and methods for using the same (2009-08-04),

13. 7435585 - Auto-stimulating cells and methods for making and using the same (2008-10-14),

14. 6797489 - PP14 fusion proteins and methods for making and using the same (2004-09-28),

15. 6316256 - Method for protein transfer (2001-11-13),

Title: The Innovative Journey of Mark L Tykocinski

Introduction: Mark L Tykocinski is a renowned inventor hailing from Merion Station, PA (US). With a passion for pushing the boundaries of science and technology, he has made significant contributions to the field of innovation.

Latest Patents: Mark L Tykocinski holds several patents in the medical and biotechnology sectors, focusing on groundbreaking advancements in treatments for various diseases and conditions.

Career Highlights: Throughout his illustrious career, Mark L Tykocinski has served in key leadership roles at prestigious research institutions and universities. His expertise in molecular biology and genetics has led to the development of cutting-edge technologies that have revolutionized the medical field.

Collaborations: Mark L Tykocinski has collaborated with leading scientists, researchers, and medical professionals from around the world to further his innovative projects. His collaborative efforts have resulted in the successful implementation of novel ideas and solutions in the healthcare industry.

Conclusion: Mark L Tykocinski's dedication to innovation and his relentless pursuit of scientific excellence have solidified his reputation as a pioneering inventor in the field of biotechnology. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.